Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Novavax's Shareholders Can Breathe a Sigh of Relief

TheMotleyFool

0 0

Novavax's Shareholders Can Breathe a Sigh of Relief

Could Novavax (NASDAQ: NVAX) climb back into positive territory in the stock market this year? On the one hand, some investors are skeptical regarding the future of the COVID-19 vaccine market, and many biotechs specializing in this niche have taken it on the chin.

On the other hand, Novavax finally cleared one of its most important (and long overdue) regulatory milestones. What's next for the vaccine maker? Let's discuss Novavax's recent regulatory win and what it means for the company's future.